Related Experiment Videos
Rearrangement of BCR genes in malignant lymphoma.
Leukemia
|June 1, 1992
Summary
The Philadelphia chromosome, a genetic marker, was found in some lymphoma patients. BCR gene rearrangements occurred in lymph nodes or bone marrow, suggesting a similar incidence to adult acute myeloid leukemia.
Area of Science:
- Oncology
- Genetics
- Hematology
Background:
- The Philadelphia chromosome (Ph) is a hallmark of chronic myelogenous leukemia (CML).
- Ph chromosome presence has been observed in other hematologic malignancies, including acute leukemias and lymphomas.
- Ph chromosome arises from a reciprocal translocation between chromosomes 9 and 22, involving the BCR and c-abl genes.
Purpose of the Study:
- To investigate the incidence of BCR gene rearrangements in patients with malignant lymphoma.
- To determine if BCR gene rearrangements are present in lymphoma without a prior CML diagnosis.
Main Methods:
- Southern blot analysis was performed on biopsy specimens.
- Analysis targeted BCR gene rearrangements.
- Specimens were from 49 patients with malignant lymphoma and no documented CML phase.
Main Results:
- BCR gene rearrangements were detected in two patients' malignant lymph nodes, but not bone marrow.
- One patient exhibited BCR gene rearrangements in bone marrow, but not in lymph nodes.
- The study suggests a similar incidence of BCR gene rearrangement in malignant lymphoma as in adult acute myeloid leukemia (AML).
Conclusions:
- BCR gene rearrangements can occur in malignant lymphoma, independent of a CML phase.
- The distribution of these rearrangements may vary between lymph nodes and bone marrow.
- The incidence appears comparable to that seen in adult AML, warranting further investigation.